Insider Selling: Marsh & McLennan Companies (NYSE:MRSH) CEO Sells $2,693,441.76 in Stock

Marsh & McLennan Companies, Inc. (NYSE:MRSH) CEO John Doyle sold 16,656 shares of the company’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the completion of the sale, the chief executive officer directly owned 116,811 shares of the company’s stock, valued at approximately $18,889,506.81. This represents a 12.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Marsh & McLennan Companies Stock Up 2.5%

Shares of NYSE:MRSH opened at $165.37 on Friday. The company has a market capitalization of $79.89 billion, a PE ratio of 20.67, a P/E/G ratio of 2.35 and a beta of 0.62. Marsh & McLennan Companies, Inc. has a twelve month low of $156.60 and a twelve month high of $231.36. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 1.28.

Marsh & McLennan Companies (NYSE:MRSH) last issued its quarterly earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, topping analysts’ consensus estimates of $3.21 by $0.08. The company had revenue of $7.30 billion during the quarter. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The firm’s quarterly revenue was up 7.6% on a year-over-year basis. On average, analysts expect that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on MRSH shares. Weiss Ratings lowered shares of Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 11th. Keefe, Bruyette & Woods boosted their target price on shares of Marsh & McLennan Companies from $200.00 to $203.00 and gave the stock a “market perform” rating in a report on Friday, April 17th. Barclays dropped their target price on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating on the stock in a report on Wednesday, April 8th. Wells Fargo & Company dropped their target price on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating on the stock in a report on Thursday, April 9th. Finally, Mizuho dropped their target price on shares of Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating on the stock in a report on Monday, April 13th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Marsh & McLennan Companies currently has a consensus rating of “Hold” and a consensus price target of $203.56.

Institutional Investors Weigh In On Marsh & McLennan Companies

A number of large investors have recently made changes to their positions in MRSH. State Street Corp acquired a new stake in shares of Marsh & McLennan Companies during the fourth quarter valued at approximately $4,057,682,000. Capital International Investors acquired a new stake in shares of Marsh & McLennan Companies during the fourth quarter valued at approximately $3,482,557,000. Capital World Investors acquired a new stake in shares of Marsh & McLennan Companies during the fourth quarter valued at approximately $3,140,284,000. Wellington Management Group LLP acquired a new position in Marsh & McLennan Companies in the 4th quarter valued at approximately $2,967,927,000. Finally, Price T Rowe Associates Inc. MD acquired a new position in Marsh & McLennan Companies in the 4th quarter valued at approximately $1,710,101,000. Institutional investors and hedge funds own 87.99% of the company’s stock.

About Marsh & McLennan Companies

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.